Is OEM or ODM service available?

Yes, OEM and ODM services are available to meet specific client needs.

What certifications does the product hold?

The product is certified with ISO standards.

What are the payment terms?

Payment terms include LC, T/T, D/P, PayPal, Western Union, and small-amount payment.

Improve Feed Utilization Improve Production Performance Monobutyrin Powder CAS 557-25-5 with ISO Standard

Name: Improve Feed Utilization Improve Production Performance Monobutyrin Powder CAS 557-25-5 with ISO Standard
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1989321192

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$4.00-6.00

1,000 kg

Sample price:US$10.00/kg.Request sample

Product profile

Customization

Available

Certification

ISO, ISO

Shape

Powder

Model NO.

Powder

Type

Lipid

Function

Nutrition Enhancer

Transport Package

Carton

Specification

25kg/Drum

Trademark

Moosun

Origin

China

HS Code

2915900090

Production Capacity

50000kg/Mouth

Key features

Improves Feed Utilization: Enhances feed efficiency and production performance in animals.

Promotes Intestinal Health: Supports intestinal mucosa development and repairs damage caused by stress.

High Absorption Efficiency: Naturally occurring ingredients with stable molecular structure and high absorption.

ISO Standard Certified: Product meets international ISO certification standards for quality.

Effective Against Pathogens: Shows 50% higher inhibitory effect on Salmonella Typhimurium and C. perfringens.

Long Shelf Life: 24 months shelf life when stored in a dry and cool place.

OEM/ODM Services Available: Customization options available for tailored product solutions.

Versatile Animal Application: Suitable for swine, poultry, aquatic animals, and grass carp.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤15h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.